Design and rationale for a comparison study of Olmesartan and Valsartan On myocardial metabolism In patients with Dilated cardiomyopathy (OVOID) trial: study protocol for a randomized controlled trial

Design and rationale for a comparison study of Olmesartan and Valsartan On myocardial metabolism In patients with Dilated cardiomyopathy (OVOID) trial: study protocol for a randomized controlled trial

Abstract Background Dilated cardiomyopathy (DCMP) is characterized by ventricular chamber enlargement and systolic dysfunction which may cause heart failure. Patients with DCMP have overactivation of the renin-angiotensin-aldosterone systems, which can also adversely affect myocardial metabolism in...

Full description

Bibliographic Details
Main Authors: Sua Jo, Hyeyeon Moon, Kyungil Park, Chang-Bae Sohn, Jeonghwan Kim, Yong-Seop Kwon, Su Hong Kim
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Trials
Subjects:
Olmesartan
Valsartan
Myocardial metabolism
Positron emission tomography
Online Access:https://doi.org/10.1186/s13063-021-05970-7

Internet

https://doi.org/10.1186/s13063-021-05970-7

Similar Items